Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer W Carlisle

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer|August 21, 2023
Advancing immunotherapy in small cell lung cancerJennifer W Carlisle, Ticiana Leal
Future Oncology (London, England)|January 19, 2019
Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancerJennifer W Carlisle, Suresh S Ramalingam
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer TherapiesJennifer W Carlisle, R Donald Harvey
Future Oncology (London, England)|September 3, 2024
Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS studySuresh S Ramalingam, Jennifer W Carlisle
Expert Opinion on Investigational Drugs|January 12, 2018
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinomaMehmet Asim Bilen, Jennifer W Carlisle, Guru Sonpavde
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2020
Integrating Genetic and Genomic Testing Into Oncology PracticeSusan M Domchek, Elaine Mardis, Jennifer W Carlisle, et al.
CA: a Cancer Journal for Clinicians|August 26, 2020
An update on the immune landscape in lung and head and neck cancersJennifer W Carlisle, Conor E Steuer, Taofeek K Owonikoko, et al.
Future Oncology (London, England)|November 27, 2024
Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancerJordyn P Higgins, Jennifer W Carlisle, Nader H Moniri, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2025
Bispecific Antibodies in Non-Small Cell Lung Cancer: From Targeted Innovation to Real-World IntegrationJennifer W Carlisle, Zachary Wolner, Sagal Pannu, et al.
JCO Oncology Practice|July 8, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine NeoplasmsJennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer|August 21, 2023
Advancing immunotherapy in small cell lung cancerJennifer W Carlisle, Ticiana Leal
Future Oncology (London, England)|January 19, 2019
Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancerJennifer W Carlisle, Suresh S Ramalingam
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer TherapiesJennifer W Carlisle, R Donald Harvey
Future Oncology (London, England)|September 3, 2024
Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS studySuresh S Ramalingam, Jennifer W Carlisle
Expert Opinion on Investigational Drugs|January 12, 2018
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinomaMehmet Asim Bilen, Jennifer W Carlisle, Guru Sonpavde
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2020
Integrating Genetic and Genomic Testing Into Oncology PracticeSusan M Domchek, Elaine Mardis, Jennifer W Carlisle, et al.
CA: a Cancer Journal for Clinicians|August 26, 2020
An update on the immune landscape in lung and head and neck cancersJennifer W Carlisle, Conor E Steuer, Taofeek K Owonikoko, et al.
Future Oncology (London, England)|November 27, 2024
Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancerJordyn P Higgins, Jennifer W Carlisle, Nader H Moniri, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2025
Bispecific Antibodies in Non-Small Cell Lung Cancer: From Targeted Innovation to Real-World IntegrationJennifer W Carlisle, Zachary Wolner, Sagal Pannu, et al.
JCO Oncology Practice|July 8, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine NeoplasmsJennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, et al.
Pageof 3